Further strengthening this suggestion, cathepsin inhibitor 1, which inhibits endosomal cathepsin L crucial for SARS-CoV-2 endosomal fusion and infection (31–34), nearly abolished V-EGFP expression without affecting V-A647 uptake (Fig. 2H and 2I). Here, CTSL is linked to infection.